Document Detail

Challenges in the diagnosis and treatment of pulmonary arterial hypertension.
MedLine Citation:
PMID:  23204119     Owner:  NLM     Status:  In-Data-Review    
Advances in the diagnosis and management of pulmonary arterial hypertension (PAH) have resulted in significant improvements in outcomes for patients with this devastating and progressive disease. However, because of the non-specific nature of its symptoms, and the low level of suspicion among clinicians, prompt and accurate diagnosis of PAH as a rare disease remains a challenge. This article explains some of the issues that need to be addressed when faced with a patient with suspected PAH and describes how noninvasive and invasive techniques can be used effectively to ensure an accurate diagnosis. The availability of PAH-specific therapy means that once diagnosed, patients have a much greater chance of survival than they would have had in the past. However, despite improved survival, mortality is still high and, therefore, there is still room for improvement. It is currently recommended that patients with an inadequate clinical response to treatment receive sequential combination therapy; however, supportive data are still scarce. Although there is no clear explanation, these findings may be explained by the design and end-points chosen in clinical trials, the changing population of PAH and a need to improve the management strategy in this disease. Indeed, there is a clear need for randomised controlled studies that investigate whether adopting individualised treatment strategies, including upfront combination therapy, could help to optimise long-term management of patients with PAH.
Jean-Luc Vachiéry; Sean Gaine
Related Documents :
1934899 - Physician-administered office anesthesia.
2244439 - Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylax...
15933289 - Crisis management during anaesthesia: awareness and anaesthesia.
24319219 - The diagnosis and treatment of venous thromboembolism.
772369 - Perspectives in physiological monitoring.
21556889 - Controversies in ivm.
1036539 - Adverse reactions in treatment with lithium carbonate and haloperidol.
21050029 - Management of complete ureteral avulsion and literature review: a report on four cases.
10897129 - Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. a ch...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European respiratory review : an official journal of the European Respiratory Society     Volume:  21     ISSN:  1600-0617     ISO Abbreviation:  Eur Respir Rev     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111391     Medline TA:  Eur Respir Rev     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  313-20     Citation Subset:  IM    
Pulmonary Vascular Diseases and Heart Failure Clinic, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. # National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early detection and management of pulmonary arterial hypertension.
Next Document:  Pathways in pulmonary arterial hypertension: the future is here.